Polypeptoid-block-polypeptide copolymers: synthesis, characterization, and application of amphiphilic block Copolypept(o)ides in drug formulations and miniemulsion techniques

Biomacromolecules
Alexander BirkeMatthias Barz

Abstract

We report the synthesis of polysarcosine-block-polyglutamic acid benzylester (PSar-block-PGlu(OBn)) and polysarcosine-block-polylysine-ε-N-benzyloxycarbonyl (PSar-block-PLys(Z)) copolymers. The novel polypeptoid-block-polypeptide copolymers (Copolypept(o)ides) have been synthesized by ring-opening polymerization (ROP) of N-carboxyanhydrides (NCAs). Polymerization conditions were optimized regarding protecting groups, block sequence and length. While the degree of polymerization of the PSar block length was set to be around 200 or 400, PGlu(OBn) and PLys(Z) block lengths were varied between 20 to 75. The obtained block copolymers had a total degree of polymerization of 220-475 and dispersity indices between 1.1 and 1.2. Having ensured a nontoxic behavior up to a concentration of 3 mg/mL in HEK293 cells, the novel block copolymers have been applied to the synthesis of organic colloids (by miniemulsion polymerization and miniemulsion solvent evaporation process). Colloids of around 100 nm (miniemulsion polymerization) to 200 nm (miniemulsion process) have been prepared. Additionally, PSar-block-PGlu(OBn) copolymers have been used in a drug formulation of an adenylate cyclase inhibitor. Micelles of 28.0 nm (without drug) and 33.0 n...Continue Reading

References

Jan 1, 1991·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·C Lippe, C Ardizzone
Aug 1, 1983·The Journal of Cell Biology·R HalabanA B Lerner
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·T KidchobY Imanishi
Dec 1, 2001·Expert Opinion on Biological Therapy·V AlakhovA Kabanov
May 17, 2003·Nature Reviews. Drug Discovery·Ruth Duncan
Dec 19, 2003·Chemical Communications : Chem Comm·Ivaylo Dimitrov, Helmut Schlaad
Mar 23, 2004·Pharmaceutical Research·Robert G Strickley
Sep 14, 2004·Biomacromolecules·Thrasyvoulos AliferisNikos Hadjichristidis
Dec 4, 2008·Faraday Discussions·Hannah LomasGiuseppe Battaglia
Mar 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Brian R McNaughtonDavid R Liu
May 23, 2009·Cancer Science·Yasuhiro Matsumura, Kazunori Kataoka
Jul 30, 2009·Biomacromolecules·Volker Mailänder, Katharina Landfester
Sep 22, 2009·Angewandte Chemie·Richard Hoogenboom
Dec 17, 2009·Advanced Drug Delivery Reviews·M TalelliW E Hennink
Jun 15, 2010·Nano Today·Margaret A PhillipsNicholas A Peppas
Oct 22, 2010·Biomacromolecules·Kristin RauschManfred Schmidt
Mar 3, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Muthu K KathiravanKishor S Jain
Apr 11, 2012·Biomacromolecules·Christina TangSaad A Khan
May 15, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Medha D JoshiEnrico Mastrobattista
Jun 1, 2013·ACS Nano·Jing Sun, Ronald N Zuckermann
Jan 21, 2011·Journal of Materials Chemistry·Mingyan ZhouGeorges Belfort

❮ Previous
Next ❯

Citations

Jul 28, 2016·Chemistry of Materials : a Publication of the American Chemical Society·Sunting XuanDonghui Zhang
Sep 24, 2015·Macromolecular Rapid Communications·Kristina Klinker, Matthias Barz
Dec 25, 2015·Chemical Reviews·Niklas GangloffRobert Luxenhofer
Mar 24, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jianwei DuYouxiang Wang
Oct 9, 2015·Nanomedicine·Elise Anne LepeltierRudolf Zentel
Nov 2, 2014·Macromolecular Rapid Communications·Philipp HellerMatthias Barz
Apr 9, 2015·Macromolecular Bioscience·Christian SeckerHelmut Schlaad
May 20, 2017·The Journal of Physical Chemistry. a·Tianwen Bai, Jun Ling
Jun 28, 2017·ACS Applied Materials & Interfaces·Lipeng ZhuLichen Yin
Oct 27, 2017·Biopolymers·Brandon A ChanDonghui Zhang
Oct 13, 2017·Macromolecular Bioscience·Tanja Weil, Matthias Barz
Aug 2, 2017·Macromolecular Bioscience·Benjamin WeberMatthias Barz
Jan 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Saide CuiKai Guo
Apr 11, 2019·Polymers·Philipp Michael KleinMatthias Barz
Apr 25, 2019·Chemical Science·Warren ViricelBenoît Joseph
Nov 24, 2020·Macromolecular Rapid Communications·Yue Tao, Youhua Tao
Dec 17, 2020·Polymers·Dandan Liu, Jing Sun
Jan 17, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Annette I S van den BergWim E Hennink
Apr 9, 2021·Biomacromolecules·Tobias A BauerMatthias Barz
Aug 11, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Tobias Alexander BauerMatthias Barz
Jul 31, 2019·Biomacromolecules·Yangwei DengMin-Hui Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.